Related Experiment Video
Updated: Feb 28, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Impact of using PRS-CSx and pruning and thresholding for polygenic partitioning of apparent treatment resistant
Hannah M Seagle1, Jeewoo Kim2, Alexis T Akerele3
1Vanderbilt Genetics Institute, Medical Center, Nashville, TN, 37203, USA2Division of Genetic Medicine, Medical Center, Nashville, TN, 37203, USA3Department of Medicine, Medical Center, Nashville, TN, 37203, USA4Division of Epidemiology, Medical Center, Nashville, TN, 37203, USA9Joseph Maxwell Cleland Atlanta VA Medical Center, Atlanta, GA, 37203, USA.
Abstract:
Apparent treatment-resistant hypertension (aTRH) is a clinically challenging condition with heterogeneous etiologies. Understanding the biological pathways underlying resistance to antihypertensive treatment could inform targeted therapeutic strategies. To evaluate how methodological choices in SNP selection influence biological inference, we applied two approaches to select aTRH-associated variants for clustering: PRS-CSx and pruning and thresholding (P&T). Using k-means clustering, we grouped aTRH-associated variants based on their association profiles across 91 cardiometabolic-related phenotypes. We then performed pathway and tissue enrichment analyses to evaluate the biological processes represented by each cluster. Both methods identified multiple genetic clusters, but the distribution of variants and biological signals differed. Clustering based on PRS-CSx produced unequally distributed clusters of SNPs and yielded limited tissue enrichment, while P&T-based clustering captured more uniform trends across cardiometabolic traits and broader tissue and pathway enrichment. These results demonstrate that methodological choices in SNP selection influence downstream clustering and biological interpretation. Despite some overlap in identified pathways and tissue enrichment, each approach identified unique biological signals, highlighting the potential of pairing polygenic methods and k-means clustering to elucidate the biological heterogeneity of aTRH and guide future mechanistic studies.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Principles of Pharmacogenetics: Types of Genetic Variants
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
